Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone [Phase 1]
Phase 1 study evaluating autologous bone marrow transplantation delivered via a transendocardial catheter in patients with ventricular dysfu…
-
CLINICAL_TRIALS research · 2009-11-02Clinical Trial Update: Registry for Acute Decompensated Heart Failure Patients
The registry for acute decompensated heart failure patients sponsored by Scios, Inc. has completed.
-
FDA approval · 2009-10-30FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for Enalapril maleate and hydrochlorothiazide from Taro Pharmaceuticals U.S.A., Inc. to update t…
-
FDA approval · 2009-10-29FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA granted supplemental approval for Lupin Pharmaceuticals’ ramipril generic under the ANDA, authorizing continued marketing of the product…
-
CLINICAL_TRIALS trial_result · 2009-10-28Clinical Trial Update: Effects of Chocolate in Patients With Chronic Heart Failure [NA]
A completed clinical trial conducted by the University of Zurich investigating the effects of chocolate on patients with chronic heart failu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for RAMIPRIL submitted by Chartwell RX, LLC., indicating approval of a supplemental filing related t…
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ramipril submitted by Hikma Pharmaceuticals USA Inc. The action confirms continued approval …
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: Allopurinol in Chronic Heart Failure [Phase 4]
A Phase 4 clinical trial evaluating allopurinol in patients with chronic heart failure (and hyperuricemia) has completed. The document notes…
-
FDA approval · 2009-10-16FDA Approved: CHLOROTHIAZIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original abbreviated new drug application for chlorothiazide sodium, a thiazide diuretic. The product…
-
CLINICAL_TRIALS trial_result · 2009-10-16Clinical Trial Update: A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects [Phase 1, Phase 2]
The study evaluated repeat-dose subcutaneous darbepoetin alfa in subjects with congestive heart failure and anemia, plus a single-dose contr…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function [Phase 3]
Phase 3 trial PROTECT-2 evaluated KW-3902, a selective A1 adenosine receptor antagonist, in patients hospitalized with acute heart failure a…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function [Phase 3]
The Phase 3 PROTECT-1 trial of KW-3902, a selective A1 adenosine receptor antagonist, in patients hospitalized with acute heart failure and …
-
CLINICAL_TRIALS other · 2009-10-09Clinical Trial Update: Ursodeoxycholic Acid in Chronic Heart Failure [Phase 2]
This clinical trial update covers a Phase 2 study of ursodeoxycholic acid for chronic heart failure, but the current trial status is unknown…
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure [NA]
This update reports the completion of a clinical trial evaluating 4 weeks of Acipimox treatment in patients with chronic heart failure. The …
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: The Effect of Action Control Based Intervention on Adherence After Cardiac Rehabilitaiton [Phase 1]
Phase 1 clinical trial evaluating an action-control based intervention to improve adherence after cardiac rehabilitation in heart failure pa…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure [NA]
A completed clinical trial sponsored by Universität des Saarlandes evaluating the benefit of exercise for patients with chronic heart failur…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Registry of Patients Referred for Heart Transplantation
A completed clinical trial registry update detailing patients referred for heart transplantation at the National Institute of Cardiology in …
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Chronic Sildenafil Treatment in Heart Failure [Phase 3]
A Phase 3 trial evaluating chronic sildenafil treatment for heart failure has completed.
-
CLINICAL_TRIALS research · 2009-09-09Clinical Trial Update: VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial [Phase 3]
This update covers a pivotal Phase 3 trial evaluating the VentrAssist LVAD as a bridge to heart transplantation for patients with end-stage …
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy [Phase 3]
Phase 3 trial update for the VentrAssist LVAD as destination therapy in advanced heart failure; the snippet does not report trial results.
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure [Phase 2]
The Phase 2 DIAMOND study evaluating distensibility improvement and remodeling in diastolic heart failure has completed.
-
CLINICAL_TRIALS research · 2009-08-28Clinical Trial Update: LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure [Phase 4]
A Phase 4 clinical trial update on long-term oxygen therapy in COPD patients with moderate chronic hypoxemia and chronic heart failure; curr…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Attain Model 4196 Left Ventricular (LV) Lead [NA]
The clinical trial evaluating Medtronic's Attain Model 4196 left ventricular lead for heart failure has completed and posted its results.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Rehabilitation and Outcome for Patients on LVAD Support [NA]
This clinical trial update concerns rehabilitation and outcomes for patients supported with a left ventricular assist device, focusing on ex…
-
FDA approval · 2009-08-18FDA Approved: BISOPROLOL FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic version of bisoprolol fumarate from Unichem Pharmaceuticals (USA), Inc. under an Original Application. It is indicate…